Lifestyle Delivery Systems Inc. Announces the Acquisition of CSPA Group, Inc. by its Wholly-Owned Subsidiary Rêveur Holdings Inc.
VANCOUVER, British Columbia, Nov. 7, 2018 /PRNewswire/ -- Lifestyle Delivery Systems (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that on October 1, 2018, LDS' wholly-owned subsidiary Rêveur Holdings Inc. (formerly known as Adelanto Agricultural Advisors Inc.) acquired CSPA Group Inc., the holder of California licenses for Cannabis Manufacturing and Cannabis Distribution and Transportation.
CSPA Group, Inc. will now be known as Rêveur Corporation. Kelly Christopherson will continue as CEO of Rêveur Corporation. LDS' CEO, Brad Eckenweiler, stated, "This acquisition will allow for a seamless relationship between LDS and our licensees." The Company expects all operations and relationships to continue without interruption through this transition.
About Rêveur Corporation
The Company is located in Adelanto, California and is a City permitted and State Licensed manufacturer and distributor/transporter in the California cannabis industry. Manufacturing extracted oils and distillates, and producing CannaStrips™ under a license agreement with Lifestyle Delivery Systems Inc.
About Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to any other form of delivery but also allows for inclusion of a wide spectrum of ingredients from over the counter medications to homeopathic, nutraceutical, vitamins and supplements. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.
On behalf of the board of directors of Lifestyle Delivery Systems Inc.
FOR MORE INFORMATION, PLEASE CONTACT:
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lifestyle-delivery-systems-inc-announces-the-acquisition-of-cspa-group-inc-by-its-wholly-owned-subsidiary-reveur-holdings-inc-300745435.html
SOURCE Lifestyle Delivery Systems Inc.
Company Codes: CNSX:LDS, Frankfurt:LD6, OTC-PINK:LDSYF, OTC-QX:LDSYF